Screener
Eligibility screening
A Phase 1b Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease
3 US sites in AL, IN, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A Phase 1b Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease
3 US sites in AL, IN, NY
Before we begin
Your answer affects how the questions are phrased.